Petersen B H, Heim M C, White J F
Lilly Laboratory for Clinical Research, Eli Lilly and Company, Indianapolis, Indiana.
Diagn Clin Immunol. 1988;5(6):349-54.
In these studies we report the induction, by 7,8-dimethoxy-1H-3-benzaepin-2-amine HCl, of immune thrombocytopenia in monkeys and its characterization by flow cytometry. Three of eight monkeys developed thrombocytopenia following administration of high doses (35 mg/kg) of the drug. The characteristics of the thrombocytopenia, including rapid induction on rechallenge with the drug, met the criteria indicative of drug-induced immune thrombocytopenia. Platelet surface-associated immunoglobulin could be detected by flow cytometry as early as 21 days before the onset of thrombocytopenia. A critical concentration of antibody on the platelet surface appeared to be necessary for elimination of the platelets from the blood. Evidence from experiments using the serum from an affected monkey suggested that drug interaction with the platelet surface produced a site for antibody binding, possibly a neoantigen, which required the continued presence of the drug.
在这些研究中,我们报告了盐酸7,8 - 二甲氧基 - 1H - 3 - 苯并氮杂卓 - 2 - 胺在猴子中诱导免疫性血小板减少症及其通过流式细胞术进行的特征描述。八只猴子中有三只在给予高剂量(35毫克/千克)该药物后出现血小板减少症。血小板减少症的特征,包括再次给药时迅速诱导,符合药物诱导的免疫性血小板减少症的标准。早在血小板减少症发作前21天,就可以通过流式细胞术检测到血小板表面相关免疫球蛋白。血小板表面抗体的临界浓度似乎是血小板从血液中清除所必需的。使用受影响猴子的血清进行的实验证据表明,药物与血小板表面的相互作用产生了抗体结合位点,可能是一种新抗原,这需要药物持续存在。